These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26085906)

  • 41. Lifestyle interventions for non-alcoholic fatty liver disease.
    Ahmed IA; Mikail MA; Mustafa MR; Ibrahim M; Othman R
    Saudi J Biol Sci; 2019 Nov; 26(7):1519-1524. PubMed ID: 31762620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Abe RAM; Masroor A; Khorochkov A; Prieto J; Singh KB; Nnadozie MC; Abdal M; Shrestha N; Mohammed L
    Cureus; 2021 Aug; 13(8):e16855. PubMed ID: 34522493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapies in non-alcoholic steatohepatitis (NASH).
    Oseini AM; Sanyal AJ
    Liver Int; 2017 Jan; 37 Suppl 1(Suppl 1):97-103. PubMed ID: 28052626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report.
    Cuschieri JR; John BK; Miick R; Ortiz JA; Hashemi N
    J Clin Exp Hepatol; 2013 Mar; 3(1):70-4. PubMed ID: 25755474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.
    Yousef MH; Al Juboori A; Albarrak AA; Ibdah JA; Tahan V
    World J Gastrointest Pathophysiol; 2017 Aug; 8(3):100-107. PubMed ID: 28868179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Management of non alcoholic fatty liver diseases in adults].
    Pariente A
    Rev Prat; 2012 Dec; 62(10):1421-5. PubMed ID: 23424926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Nonalcoholic fatty liver disease].
    Lemoine M; Serfaty L
    Presse Med; 2012 Feb; 41(2):169-89. PubMed ID: 21723084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
    Federico A; Zulli C; de Sio I; Del Prete A; Dallio M; Masarone M; Loguercio C
    World J Gastroenterol; 2014 Dec; 20(45):16841-57. PubMed ID: 25492998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Non-alcoholic fatty liver disease and steatohepatitis].
    Pár G; Horváth G; Pár A
    Orv Hetil; 2013 Jul; 154(29):1124-34. PubMed ID: 23853345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Said A; Ghufran A
    World J Clin Oncol; 2017 Dec; 8(6):429-436. PubMed ID: 29291167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
    Byrne CD
    Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.